These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38275936)
1. B and T Cell Responses to SARS-CoV-2 Vaccination in Kidney and Liver Transplant Recipients with and without Previous COVID-19. Watschinger C; Stampfel G; Zollner A; Hoog AM; Rössler A; Reiter S; Dax K; Kimpel J; Tilg H; Antlanger M; Schwaiger E; Moschen AR Viruses; 2023 Dec; 16(1):. PubMed ID: 38275936 [TBL] [Abstract][Full Text] [Related]
2. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients. Rabinowich L; Grupper A; Baruch R; Ben-Yehoyada M; Halperin T; Turner D; Katchman E; Levi S; Houri I; Lubezky N; Shibolet O; Katchman H J Hepatol; 2021 Aug; 75(2):435-438. PubMed ID: 33892006 [TBL] [Abstract][Full Text] [Related]
3. Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients. Toniutto P; Falleti E; Cmet S; Cussigh A; Veneto L; Bitetto D; Fornasiere E; Fumolo E; Fabris C; Sartor A; Peressutti R; Curcio F; Regattin L; Grillone L J Hepatol; 2022 Jul; 77(1):152-162. PubMed ID: 35283215 [TBL] [Abstract][Full Text] [Related]
7. Low switched memory B cells are associated with no humoral response after SARS-CoV-2 vaccine boosters in kidney transplant recipients. Seija M; García-Luna J; Rammauro F; Brugnini A; Trías N; Astesiano R; Santiago J; Orihuela N; Zulberti C; Machado D; Recalde C; Yandián F; Guerisoli A; Noboa J; Orihuela S; Curi L; Bugstaller E; Noboa O; Nin M; Bianchi S; Tiscornia A; Lens D Front Immunol; 2023; 14():1202630. PubMed ID: 37942335 [TBL] [Abstract][Full Text] [Related]
8. Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients. Murray SM; Pose E; Wittner M; Londoño MC; Schaub G; Cook J; Dimitriadis S; Meacham G; Irwin S; Lim Z; Duengelhoef P; Sterneck M; Lohse AW; Perez V; Trivedi P; Bhandal K; Mullish BH; Manousou P; Provine NM; Avitabile E; Carroll M; Tipton T; Healy S; Burra P; Klenerman P; Dunachie S; Kronsteiner B; Maciola AK; Pasqual G; Hernandez-Gea V; Garcia-Pagan JC; Lampertico P; Iavarone M; Gines P; Lütgehetmann M; Schulze Zur Wiesch J; Russo FP; Barnes E; Marjot T; J Hepatol; 2024 Jan; 80(1):109-123. PubMed ID: 37863203 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients. Ruether DF; Schaub GM; Duengelhoef PM; Haag F; Brehm TT; Fathi A; Wehmeyer M; Jahnke-Triankowski J; Mayer L; Hoffmann A; Fischer L; Addo MM; Lütgehetmann M; Lohse AW; Schulze Zur Wiesch J; Sterneck M Clin Gastroenterol Hepatol; 2022 Jan; 20(1):162-172.e9. PubMed ID: 34509643 [TBL] [Abstract][Full Text] [Related]
10. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients. Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758 [TBL] [Abstract][Full Text] [Related]
11. Assessment of humoral and cellular immune responses to SARS CoV-2 vaccination (BNT162b2) in immunocompromised renal allograft recipients. Zhang R; Shin BH; Gadsden TM; Petrosyan A; Vo A; Ammerman N; Sethi S; Huang E; Peng A; Najjar R; Atienza J; Kim I; Jordan SC Transpl Infect Dis; 2022 Apr; 24(2):e13813. PubMed ID: 35202497 [TBL] [Abstract][Full Text] [Related]
12. Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients. Harberts A; Schaub GM; Ruether DF; Duengelhoef PM; Brehm TT; Karsten H; Fathi A; Jahnke-Triankowski J; Fischer L; Addo MM; Haag F; Luetgehetmann M; Lohse AW; Schulze Zur Wiesch J; Sterneck M Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2558-2566.e5. PubMed ID: 35850415 [TBL] [Abstract][Full Text] [Related]
13. Evolution of humoral immune response to SARS-CoV-2 mRNA vaccine in liver transplant recipients - a longitudinal study. Schoepf IC; Riebensahm C; Becchetti C; Blaser V; Unternährer CV; Banz V; Hirzel C; Suter-Riniker FM; Berzigotti A Swiss Med Wkly; 2023 Oct; 153():40118. PubMed ID: 37955624 [TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipients. Meunier L; Sanavio M; Dumortier J; Meszaros M; Faure S; Ursic Bedoya J; Echenne M; Boillot O; Debourdeau A; Pageaux GP Liver Int; 2022 Aug; 42(8):1872-1878. PubMed ID: 35338550 [TBL] [Abstract][Full Text] [Related]
15. B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients. Schrezenmeier E; Rincon-Arevalo H; Stefanski AL; Potekhin A; Staub-Hohenbleicher H; Choi M; Bachmann F; Proβ V; Hammett C; Schrezenmeier H; Ludwig C; Jahrsdörfer B; Lino AC; Eckardt KU; Kotsch K; Dörner T; Budde K; Sattler A; Halleck F J Am Soc Nephrol; 2021 Dec; 32(12):3027-3033. PubMed ID: 34667083 [TBL] [Abstract][Full Text] [Related]
16. Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic. Reischig T; Kacer M; Vlas T; Drenko P; Kielberger L; Machova J; Topolcan O; Kucera R; Kormunda S Am J Transplant; 2022 Mar; 22(3):801-812. PubMed ID: 34860470 [TBL] [Abstract][Full Text] [Related]
17. Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort. Zecca E; Rizzi M; Tonello S; Matino E; Costanzo M; Rizzi E; Casciaro GF; Manfredi GF; Acquaviva A; Gagliardi I; Calzaducca E; Mallela VR; D'Onghia D; Minisini R; Bellan M; Castello LM; Gavelli F; Avanzi GC; Patrucco F; Chiocchetti A; Pirisi M; Rigamonti C; Lilleri D; Sola D; Sainaghi PP Viruses; 2022 Aug; 14(8):. PubMed ID: 36016388 [TBL] [Abstract][Full Text] [Related]
18. Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls. Hamm SR; Møller DL; Pérez-Alós L; Hansen CB; Pries-Heje MM; Heftdal LD; Hasselbalch RB; Fogh K; Madsen JR; Almagro Armenteros JJ; Knudsen AD; Poulsen JR; Frikke-Schmidt R; Hilsted LM; Sørensen E; Ostrowski SR; Harboe ZB; Perch M; Sørensen SS; Rasmussen A; Bundgaard H; Garred P; Iversen K; Nielsen SD Front Immunol; 2022; 13():832501. PubMed ID: 35281023 [TBL] [Abstract][Full Text] [Related]